` NYKD (Nykode Therapeutics ASA) vs VRTX (Vertex Pharmaceuticals Inc) Comparison - Alpha Spread

N
NYKD
vs
VRTX

Over the past 12 months, NYKD has significantly outperformed VRTX, delivering a return of +104% compared to the VRTX's 11% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NYKD
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NYKD Intrinsic Value
LOCKED
Unlock
VRTX Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
N
Nykode Therapeutics ASA
OSE:NYKD
3.2 NOK
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
433.5 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NYKD, VRTX

NYKD
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
Nykode Therapeutics ASA
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NYKD, VRTX

NYKD
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
Nykode Therapeutics ASA
OSE:NYKD
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NYKD
0%
VRTX
86.2%

Operating Margin

NYKD
0%
VRTX
39%

Net Margin

NYKD
0%
VRTX
32.9%

FCF Margin

NYKD
0%
VRTX
26.6%

ROE

NYKD
-10.8%
VRTX
22.5%

ROA

NYKD
-9.7%
VRTX
16.4%

ROIC

NYKD
-56.9%
VRTX
26.9%

ROCE

NYKD
-24.1%
VRTX
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NYKD, VRTX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NYKD, VRTX

Performance Gap Between NYKD and VRTX
LOCKED
Unlock

Performance By Year
NYKD, VRTX

Loading
NYKD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NYKD to other stocks
PNEXF
Pharnext SCA
More expensive
vs NYKD
ABBV
Abbvie Inc
Cheaper
vs NYKD
AMGN
Amgen Inc
Cheaper
vs NYKD
GILD
Gilead Sciences Inc
Cheaper
vs NYKD
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett